Lecture 23: Asthma Drugs Flashcards

1
Q

Short-acting B2 agonist (SABA) use

A

-PRN for acute attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SABA drugs

A

-albuterol
-terbutaline
-metaproterenol
-pirbuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Long acting B2 agonists (LABA) uses

A

-additional therapy in pts using inhaled glucocotricoids
-daily use
-not for acute attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LABA black box warning

A

-not an anti-inflammatory
-should NOT be used as monotherapy for asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LABA drugs

A

-salmeterol
-formoterol

-commonly available with cortiosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metaproterenol

A

-SABA
-4 hour
-analog of isoproterenol
-least potent B2 agonist
-good oral availability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Terbutaline

A

-SABA
-N-t-butyl analog of metaproterenol
-greater B2 selectivity
-3x more potent than metaproterenol
-good oral availability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Albuterol

A

-SABA
-most used
-4-8hour
-salicyl alcohol in phenyl = COMT resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Levalbuterol

A

-R-isomer or albuterol
-greater potency
-more expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pirbuterol

A

-SABA
-analogous to albuterol except the pyridine ring
-similar duration but less potent than albuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Salmeterol

A

-LABA
-available as powder
-greater lipid solubility;dissolve in cell membranes
-12 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Formoterol

A

-LABA
-available as powder
-more rapid onset but similar duration to salmeterol
-resistant to COMT and MAO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inhaled Corticosteroids (ICSs)

A

-maintenance therapy for persistant asthma
-not curative (effective only when taken)
-systemic/oral admin for severe cases only
-most effective way to minimize systemic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inhaled corticosteroids (ICSs) drugs

A

-triamcinolone acetonide
-beclomethasone dipropionate
-budesonide
-flunisolide
-mometasone furoate
-fluticasone propionate
-ciclesonide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ICS adverse effects

A

-candidiasis
-hoarseness (effect on vocal cords)
-long-term inc risk of osteoporosis and cataracts
-1 cm reduction of growth of children in the first year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Candidiasis treatment

A

-clotrimazole
-reduced by gargling water after each use
-ciclesonide (21-ester prodrug) associated w less effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Leukotrienes

A

-produced from arachidonic acid by 5-lipoxygenase
-involved in inflammatory diseases and anaphylaxis

18
Q

LTB4

A

-potent neutrophil chemoattractant
-leukotriene

19
Q

LTC 4 and LTD4

A

-bronchoconstriction
-inc bronchial reactivity
-mucosal edema
-mucus hypersecretion

20
Q

Leukotriene pathway inhibitors

A

-improve asthma control
-reduce freq of exacerbations
-not as effective as ICSs
-effective orally
-reduce response to aspirin in aspirin-induced asthma

21
Q

Types of leukotriene pathway inhibitors

A

-5-lipoxygenase inhibitor
-cysLTI receptor ANTagonists

22
Q

5-lipoxygenase drug

23
Q

cysLTI ANTagonist drugs

A

-Zafirlukast
-Montelukast

24
Q

Zileuton

A

-5-lipoxygenase inhibitor
-good oral availability
-alternative to LABA in addition to ICSs
-NOT for acute attack
-requires periodic monitoring of liver function

25
Montelukast
-blocks binding of LTC, LTD, LTE4 to receptor -once daily -good oral bioavailability -reduces frequency of asthma exacerbations -little toxicity
26
Methylxanthine drugs
-theophylline -theobromine -caffeine -replaced by B2 agonists but used in some countries bc it cheap
27
Methylxanthine SAR
-6-ring next to 5 ring
28
Methylxanthine drug mechanism
-inhibit phosphodiesterase -inc cAMP -bronchodilation -suppress histamine release -block adenosine action (constriction and H release) -histone deacetylation (suppresses inflammatory genes)
29
Methylxanthine toxicity
-nausea -vomiting -tremulousness -arrhythmias -narrow therapuetic index
30
Antimuscarinic agents
-anticholinergics -for pts intolerant of B agonists
31
Antimuscarinic mechanism
-inhibit acetylcholine at muscarinic receptors -doesn't allow bronchoconstriction and mucus secretion
32
Antimuscarinic drug
Ipratropium
33
Ipratropium
-bronchodilator -4' amine derivative of atropine -poorly absorbed into circulation after inhaled -minimal oral bioavailability -relatively free of systemic atropine-like effects
34
Mast cell stabilizers
-inhibit mast cell degranulation -no direct action, use daily -poorly absorbed -little toxicity -not a potent or effective as glucocorticoids -currently used for allergic rhinoconjuctivitis eye drops
35
Mast cell stabilizer drugs
-Cromolyn -Nedocromil
36
Omalizumab
-inhibits IgE binding to mast cells -reserved for patients w severe asthma and allergic sensitization
37
IL-5
-attracts and activates eosinophils
38
Anti-IL-5 mABs
-mepolizumab -Reslizumab
39
Anti-IL-5 receptos mABs
-Benralizumab
40
Anti IL-5 therapy
-used as maintenance therapy of severe asthma in pats w eosinophillic phenotype